Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 6 March 2026
Revised: 31 May 2026
Accepted: 1 June 2026
First Online: 16 June 2026
Competing interests
: MA holds minority shares in Vivam GmbH and provides unpaid consultancy services to the same company. He has contributed to the patent application WO2025109222A1. He owns/has owned stocks with potential relevance to the paper with stock tickers ABEA, CSCO, IBM. HM was a National Institute of Health Research Academic Clinical Fellow (ACF-2023-17-008) and is currently a Wellcome Trust Doctoral Fellow. TAP has received consultancy fees from Arialys Therapeutics. HM and TAP have a pending grant agreement with the OpenAI Mental Health Research Grant. This agreement was not finalized at the time of acceptance, and no funds have been received.
